180 related articles for article (PubMed ID: 34582640)
21. Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine.
Kukimoto I; Matsumoto K; Takahashi F; Iwata T; Tanaka K; Yamaguchi-Naka M; Yamamoto K; Yahata H; Nakabayashi M; Kato H; Tsuda N; Onuki M; Yaegashi N;
Tohoku J Exp Med; 2020 Aug; 251(4):287-294. PubMed ID: 32759554
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China.
Wang X; Zeng Y; Huang X; Zhang Y
Biomed Res Int; 2018; 2018():2897937. PubMed ID: 30402468
[TBL] [Abstract][Full Text] [Related]
25. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.
Zhang HY; Fei MD; Jiang Y; Fei QY; Qian H; Xu L; Jin YN; Jiang CQ; Li HX; Tiggelaar SM; Smith JS; Sahasrabuddhe VV; Qiao YL
Virol J; 2014 Dec; 11():202. PubMed ID: 25481842
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status.
Olesen TB; Iftner T; Mwaiselage J; Kahesa C; Rasch V; Ngoma T; Munk C; Kjaer SK
Sex Transm Dis; 2013 Jul; 40(7):592-8. PubMed ID: 23965778
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis.
Olesen TB; Munk C; Christensen J; Andersen KK; Kjaer SK
Sex Transm Infect; 2014 Sep; 90(6):455-62. PubMed ID: 24812407
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of high-risk HPV and its genotypes-Implications in the choice of prophylactic HPV vaccine.
Suresh A; Suresh P; Biswas R; Rajanbabu A; Sreedhar S; Biswas L
J Med Virol; 2021 Aug; 93(8):5188-5192. PubMed ID: 33851736
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security.
Salcedo M; Pina-Sanchez P; Vallejo-Ruiz V; Monroy-Garcia A; Aguilar-Lemarroy A; Cortes-Gutierrez EI; Santos-Lopez G; Montoya-Fuentes H; Grijalva R; Madrid-Marina V; Apresa-Garcia T; Hernandez DM; Jave-Suarez LF; Romero P; Poot A; Salgado E; Ramos-Gonzalez P; Gonzalez-Hernandez R; Canton JC; Jimenez-Aranda L; Parra-Melquiadez M; Paniagua L; Mendoza M; Arreola H; Villegas V; Torres-Poveda K; Bahena-Roman M; Gonzalez-Yebra B; Taniguchi K; Rodea C; Mantilla-Morales A; Mora-Garcia ML; Velazquez-Velazquez CK; Cordova-Uscanga C; Peralta R; Lopez-Romero R; Marrero D; Bandala C; Reyes-Leyva J; Furuya ME; Almeida E; Galvan ME; Grijalva I
Asian Pac J Cancer Prev; 2014; 15(23):10061-6. PubMed ID: 25556426
[TBL] [Abstract][Full Text] [Related]
30. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
de Sanjosé S; Diaz M; Castellsagué X; Clifford G; Bruni L; Muñoz N; Bosch FX
Lancet Infect Dis; 2007 Jul; 7(7):453-9. PubMed ID: 17597569
[TBL] [Abstract][Full Text] [Related]
31. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
32. [Genotype distribution and behavioral risk factor analysis of human papillomavirus infection among Kazak women in Xinjiang Uygur Autonomous Region].
Wang Y; Dong X; Zhao XL; Rezhake R; Shen GQ; Talehati D; Liu LP; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2112-2118. PubMed ID: 33378825
[No Abstract] [Full Text] [Related]
33. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.
Menon S; Wusiman A; Boily MC; Kariisa M; Mabeya H; Luchters S; Forland F; Rossi R; Callens S; Vanden Broeck D
PLoS One; 2016; 11(10):e0163965. PubMed ID: 27764092
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
[TBL] [Abstract][Full Text] [Related]
36. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
37. Prevalence of human papillomavirus DNA and p16
Olesen TB; Sand FL; Rasmussen CL; Albieri V; Toft BG; Norrild B; Munk C; Kjær SK
Lancet Oncol; 2019 Jan; 20(1):145-158. PubMed ID: 30573285
[TBL] [Abstract][Full Text] [Related]
38. Characteristic of persistent human papillomavirus infection in women worldwide: a meta-analysis.
Zhao M; Zhou D; Zhang M; Kang P; Cui M; Zhu L; Luo L
PeerJ; 2023; 11():e16247. PubMed ID: 38025679
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women.
Chen HC; You SL; Hsieh CY; Schiffman M; Lin CY; Pan MH; Chou YC; Liaw KL; Hsing AW; Chen CJ;
Int J Cancer; 2011 Mar; 128(5):1192-203. PubMed ID: 20853317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
